Cell Biotech Co., Ltd. (KOSDAQ:049960)
13,150
-70 (-0.53%)
At close: Aug 7, 2025
Cell Biotech Market Cap
Cell Biotech has a market cap or net worth of 89.93 billion as of August 8, 2025. Its market cap has decreased by -19.29% in one year.
Market Cap
89.93B
Enterprise Value
1.50B
Revenue
48.10B
Ranking
n/a
PE Ratio
6.45
Stock Price
13,150.00
Market Cap Chart
Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 89.93B, an increase of 543.82%. That is a compound annual growth rate of 8.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 90.00B | -7.85% |
Dec 30, 2024 | 97.66B | 27.18% |
Dec 28, 2023 | 76.79B | -11.65% |
Dec 29, 2022 | 86.92B | -34.80% |
Dec 30, 2021 | 133.30B | -19.84% |
Dec 30, 2020 | 166.29B | 21.02% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 460.93T |
SK hynix | 180.87T |
LG Energy Solution | 90.44T |
Samsung Biologics | 73.24T |
Hanwha Aerospace | 47.95T |
Hyundai Motor Company | 46.44T |
HD Hyundai Heavy Industries | 42.17T |
Doosan Enerbility | 41.89T |